US4152411A
(en)
|
1977-07-27 |
1979-05-01 |
Akzona Incorporated |
High specific activity labeled substances
|
CA1133829A
(fr)
|
1978-08-24 |
1982-10-19 |
Neil J.L. Gilmour |
Vaccins contre la pasteurellose
|
US4837151A
(en)
|
1980-05-19 |
1989-06-06 |
The Board Of Trustees Of The Leland Stanford Junior University, Stanford University |
Live vaccines comprising two mutations and foreign antigen
|
US5077044A
(en)
|
1980-05-19 |
1991-12-31 |
The Board Of Trustees Of The Leland Stanford Jr. University |
Novel non-reverting shigella live vaccines
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
US5360897A
(en)
|
1981-08-31 |
1994-11-01 |
The University Of Rochester |
Immunogenic conjugates of streptococcus pneumonial capsular polymer and toxin or in toxiad
|
US5097020A
(en)
|
1983-07-05 |
1992-03-17 |
The University Of Rochester |
Immunogenic conjugates
|
US4902506A
(en)
|
1983-07-05 |
1990-02-20 |
The University Of Rochester |
Immunogenic conjugates
|
US4673574A
(en)
|
1981-08-31 |
1987-06-16 |
Anderson Porter W |
Immunogenic conjugates
|
US4454121A
(en)
|
1982-07-27 |
1984-06-12 |
The University Of Tennessee Research Corporation |
Synthetic peptides corresponding to antigenic determinants of the M protein of Streptococcus pyogenes
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
US4650764A
(en)
|
1983-04-12 |
1987-03-17 |
Wisconsin Alumni Research Foundation |
Helper cell
|
US4784948A
(en)
|
1983-08-10 |
1988-11-15 |
The Rockefeller University |
Production of streptococcal m protein immunogens and molecular probes
|
US4695562A
(en)
|
1984-04-06 |
1987-09-22 |
Univ. Of Tennessee Research Corp. |
Synthetic peptide compounds
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
EP0173494A3
(fr)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Récepteurs chimériques par liaison et expression de l'ADN
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
GB8424757D0
(en)
|
1984-10-01 |
1984-11-07 |
Pasteur Institut |
Retroviral vector
|
US4720489A
(en)
|
1984-10-15 |
1988-01-19 |
Douglas Shander |
Hair growth modification with ornithine decarboxylase inhibitors
|
FR2573436B1
(fr)
|
1984-11-20 |
1989-02-17 |
Pasteur Institut |
Adn recombinant comportant une sequence nucleotidique codant pour un polypeptide determine sous le controle d'un promoteur d'adenovirus, vecteurs contenant cet adn recombinant, cellules eucaryotes transformees par cet adn recombinant, produits d'excretion de ces cellules transformees et leurs applications, notamment a la constitution de vaccins
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
US4797368A
(en)
|
1985-03-15 |
1989-01-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adeno-associated virus as eukaryotic expression vector
|
US4666829A
(en)
|
1985-05-15 |
1987-05-19 |
University Of California |
Polypeptide marker for Alzheimer's disease and its use for diagnosis
|
US5078996A
(en)
|
1985-08-16 |
1992-01-07 |
Immunex Corporation |
Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
|
US5139941A
(en)
|
1985-10-31 |
1992-08-18 |
University Of Florida Research Foundation, Inc. |
AAV transduction vectors
|
US4772584A
(en)
|
1986-05-23 |
1988-09-20 |
Cleary Paul P |
Inhibitor of C5a-mediated chemotaxis
|
IT1216262B
(it)
|
1986-09-02 |
1990-02-22 |
Bargellini Andrea |
Assorbente,ed utensile cosi'procedimento ed attrezzatura per la realizzato. formazione di un utensile di pulizia a strisce di materiale
|
EP0272929B1
(fr)
|
1986-12-24 |
1996-03-20 |
Genentech, Inc. |
Encéphalinase pour application théraupeutique
|
US5057540A
(en)
|
1987-05-29 |
1991-10-15 |
Cambridge Biotech Corporation |
Saponin adjuvant
|
US5162226A
(en)
|
1987-08-24 |
1992-11-10 |
University Of Tennessee Research Corp. (U.T.R.C.) |
Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
|
US5124153A
(en)
|
1987-08-24 |
1992-06-23 |
University Of Tennessee Research Corp. |
Therapeutic compositions against streptococcal infections, transformed hosts, methods of immunization and genetically engineered products
|
AU3069189A
(en)
|
1988-02-05 |
1989-08-25 |
Trustees Of Columbia University In The City Of New York, The |
Retroviral packaging cell lines and processes of using same
|
AU630093B2
(en)
|
1988-03-25 |
1992-10-22 |
Rockefeller University, The |
Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
CA1339354C
(fr)
|
1988-09-01 |
1997-08-26 |
The Whitehead Institute For Biomedical Research |
Retrovirus recombinants avec spectres d'activite amphotropes et ecotropes
|
JP2871709B2
(ja)
|
1988-11-21 |
1999-03-17 |
住友製薬株式会社 |
免疫グロブリンg結合活性を有する新規な蛋白質プロテインh、該蛋白質をコードする遺伝子及び該蛋白質の製造法
|
US5354844A
(en)
|
1989-03-16 |
1994-10-11 |
Boehringer Ingelheim International Gmbh |
Protein-polycation conjugates
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
CA2039921A1
(fr)
|
1990-04-16 |
1991-10-17 |
Xandra O. Breakefield |
Transfert et expression de la sequence d'adn dans les cellules du systeme nerveux central a l'aide de mutants du virus de l'herpes, avec deletions chez les genes en vue de repliquer le virus
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
WO1991018088A1
(fr)
|
1990-05-23 |
1991-11-28 |
The United States Of America, Represented By The Secretary, United States Department Of Commerce |
Vecteurs eucaryotiques a base de virus adeno-associes (aav)
|
SE9002212D0
(sv)
|
1990-06-21 |
1990-06-21 |
Hightech Receptor Ab |
Igg binding protein
|
JP3126381B2
(ja)
|
1990-07-31 |
2001-01-22 |
ジェネンテク,インコーポレイテッド |
減少されたクリアランスを有する組織プラスミノーゲンアクチベーター変異体
|
WO1992005263A1
(fr)
|
1990-09-25 |
1992-04-02 |
Cantab Pharmaceuticals Research Limited |
Vaccin viral mutant a genome deficient et produit en transcomplementant la lignee cellulaire
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
IL101715A
(en)
|
1991-05-02 |
2005-06-19 |
Amgen Inc |
Recombinant dna-derived cholera toxin subunit analogs
|
US6100380A
(en)
|
1991-10-28 |
2000-08-08 |
Cytran, Inc. |
Immunomodulating peptides and methods of use
|
US5252479A
(en)
|
1991-11-08 |
1993-10-12 |
Research Corporation Technologies, Inc. |
Safe vector for gene therapy
|
EP0672123A1
(fr)
|
1992-01-08 |
1995-09-20 |
The Rockefeller University |
Proteine de surface multifonctionnelle de streptococci
|
WO1993018157A1
(fr)
|
1992-03-09 |
1993-09-16 |
The Regents Of The University Of California |
Compositions et procedes d'identification et de synthese de sialyltransferases
|
WO1993021220A1
(fr)
|
1992-04-08 |
1993-10-28 |
The Council Of The Queensland Institute Of Medical Research |
Peptides synthetiques utilises dans un vaccin contre l'infection par les streptocoques et pour le diagnostic de cette infection
|
AU5128593A
(en)
|
1992-09-16 |
1994-04-12 |
University Of Tennessee Research Corporation, The |
Antigen of hybrid m protein and carrier for group a streptococcal vaccine
|
WO1994006421A1
(fr)
|
1992-09-16 |
1994-03-31 |
The University Of Tennessee Research Corporation |
Vaccin a proteine m multivalente recombinee
|
EP0673431A1
(fr)
|
1992-12-03 |
1995-09-27 |
Genzyme Corporation |
Therapie genique de la fibrose kystique
|
US5593972A
(en)
|
1993-01-26 |
1997-01-14 |
The Wistar Institute |
Genetic immunization
|
AU696336B2
(en)
|
1993-03-19 |
1998-09-10 |
Cantab Pharmaceuticals Research Limited |
Defective mutant non-retroviral virus (e.g. HSV) as vaccine
|
FR2705361B1
(fr)
|
1993-05-18 |
1995-08-04 |
Centre Nat Rech Scient |
Vecteurs viraux et utilisation en thérapie génique.
|
FR2705686B1
(fr)
|
1993-05-28 |
1995-08-18 |
Transgene Sa |
Nouveaux adénovirus défectifs et lignées de complémentation correspondantes.
|
CA2144040A1
(fr)
|
1993-07-13 |
1995-01-26 |
Michel Perricaudet |
Vecteurs adenoviraux defectifs et utilisation en therapie genique
|
EP0711354A1
(fr)
|
1993-07-30 |
1996-05-15 |
University Of Medicine & Dentistry Of New Jersey |
Transfert efficace de genes dans des lymphocytes primaires
|
FR2714830B1
(fr)
|
1994-01-10 |
1996-03-22 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
FR2715847B1
(fr)
|
1994-02-08 |
1996-04-12 |
Rhone Poulenc Rorer Sa |
Composition contenant des acides nucléiques, préparation et utilisations.
|
FR2716459B1
(fr)
|
1994-02-22 |
1996-05-10 |
Univ Paris Curie |
Système hôte-vecteur utilisable en thérapie génique.
|
AU2194895A
(en)
|
1994-03-25 |
1995-10-17 |
Uab Research Foundation, The |
Composition and methods for creating syngeneic recombinant virus-producing cells
|
CA2187818A1
(fr)
|
1994-04-15 |
1995-10-26 |
Robert W. Overell |
Proteine de fusion d'apport de gene
|
US5571515A
(en)
|
1994-04-18 |
1996-11-05 |
The Wistar Institute Of Anatomy & Biology |
Compositions and methods for use of IL-12 as an adjuvant
|
US5866135A
(en)
|
1994-04-21 |
1999-02-02 |
North American Vaccine, Inc. |
Group A streptococcal polysaccharide immunogenic compositions and methods
|
US5505947A
(en)
|
1994-05-27 |
1996-04-09 |
The University Of North Carolina At Chapel Hill |
Attenuating mutations in Venezuelan Equine Encephalitis virus
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US5679654A
(en)
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
US5837533A
(en)
|
1994-09-28 |
1998-11-17 |
American Home Products Corporation |
Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
|
FR2727679B1
(fr)
|
1994-12-05 |
1997-01-03 |
Rhone Poulenc Rorer Sa |
Nouveaux agents de transfection et leurs applications pharmaceutiques
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
FR2730637B1
(fr)
|
1995-02-17 |
1997-03-28 |
Rhone Poulenc Rorer Sa |
Composition pharmaceutique contenant des acides nucleiques, et ses utilisations
|
US7153510B1
(en)
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
AU6043396A
(en)
|
1995-06-05 |
1996-12-24 |
University Of Alabama At Birmingham Research Foundation, The |
Composition and methods for creating syngeneic recombinant v irus-producing cells
|
FR2741358B1
(fr)
|
1995-11-17 |
1998-01-02 |
Centre Nat Rech Scient |
Production de vecteurs retroviraux par l'intermediaire de vecteurs viraux a base de virus a adn
|
US5846547A
(en)
|
1996-01-22 |
1998-12-08 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
US6355255B1
(en)
*
|
1998-12-07 |
2002-03-12 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
US5829302A
(en)
|
1996-05-31 |
1998-11-03 |
The National Machinery Company |
Cassette tooling
|
IT1289387B1
(it)
|
1996-07-16 |
1998-10-02 |
Zanussi Elettromecc |
Perfezionamenti ai circuiti refrigeranti a compressione per apparecchi domestici e simili
|
AU4427897A
(en)
|
1996-09-27 |
1998-04-17 |
American Cyanamid Company |
3' genomic promoter region and polymerase gene mutations responsible for att enuation in viruses of the order designated mononegavirales
|
US6113918A
(en)
|
1997-05-08 |
2000-09-05 |
Ribi Immunochem Research, Inc. |
Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
|
CZ299473B6
(cs)
|
1997-06-30 |
2008-08-06 |
Rhone-Poulenc Rorer S. A. |
Nukleová kyselina a elektrické pole jako sdruženýprodukt pro prenos nukleové kyseliny do bunek prícne pruhovaného svalstva
|
JP2002515816A
(ja)
|
1997-06-30 |
2002-05-28 |
アバンテイス・フアルマ・エス・アー |
in vivo組織に核酸ベクターを最適に電気導入する装置
|
BR9810372A
(pt)
|
1997-06-30 |
2000-09-05 |
Rhone Poulenc Rorer Sa |
Processo de transferência de ácido nucléico para o interior de células de organismos eucarióticos pluricelulares in vivo, composição, ácido nucléico e campo elétrico, e, produto de combinação
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
DE69937571T2
(de)
|
1998-09-30 |
2008-09-04 |
The Government Of The United States Of America As Represented By The Uniformed Services University Of The Health Sciences |
Mutiertes cholera holotoxin als hilfsmittel
|
US6168911B1
(en)
|
1998-12-18 |
2001-01-02 |
Eastman Kodak Company |
Formulations for preparing metal oxide-based pigment-binder transparent electrically conductive layers
|
WO2000037648A1
(fr)
|
1998-12-22 |
2000-06-29 |
The University Of Tennessee Research Corporation |
Antigene protecteur de streptococci de groupe a (spa)
|
EP1075841A1
(fr)
|
1999-08-13 |
2001-02-14 |
Erasmus Universiteit Rotterdam |
Vaccins pneumococciques
|
US7256265B2
(en)
|
1999-12-03 |
2007-08-14 |
Regents Of The University Of Minnesota |
Streptococcal C5a peptidase vaccine
|
MXPA03003690A
(es)
*
|
2000-10-27 |
2004-05-05 |
Chiron Spa |
Acidos nucleicos y proteinas de los grupos a y b de estreptococos.
|
WO2002077183A2
(fr)
|
2001-03-21 |
2002-10-03 |
Elitra Pharmaceuticals, Inc. |
Identification de genes essentiels dans des microorganismes
|
JP2004533236A
(ja)
*
|
2001-04-13 |
2004-11-04 |
ワイエス |
化膿性連鎖球菌(Streptococcuspyogenes)の表面タンパク質
|
JP2006520202A
(ja)
*
|
2003-03-04 |
2006-09-07 |
インターツェル・アクチェンゲゼルシャフト |
ストレプトコッカス・ピオゲネス抗原
|
CN100579985C
(zh)
*
|
2003-05-07 |
2010-01-13 |
英特塞尔股份公司 |
无乳链球菌抗原ⅰ和ⅱ
|
EP1648500B1
(fr)
*
|
2003-07-31 |
2014-07-09 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions immunogenes pour streptoccus pyogenes
|
RU2263143C2
(ru)
*
|
2004-01-05 |
2005-10-27 |
ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева |
Штамм бактерий streptococcus pyogenes №289, используемый для изготовления вакцин против стрептококкоза пушных зверей
|
JP2007520718A
(ja)
|
2004-02-06 |
2007-07-26 |
カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ |
治療可能性のあるアドヘシンおよびアドヘシン様タンパク質を同定するためのコンピュータを利用した方法
|
AU2005258397A1
(en)
*
|
2004-07-01 |
2006-01-12 |
Daiichi Pharmaceutical Co., Ltd. |
Pyrazole derivatives
|
CN103360485A
(zh)
*
|
2004-08-18 |
2013-10-23 |
诺瓦生命科学有限公司 |
包含含有精氨酸和/或赖氨酸的基序的抗微生物肽
|
EP1807446A2
(fr)
*
|
2004-10-08 |
2007-07-18 |
Novartis Vaccines and Diagnostics, Inc. |
Compositions immunogenes et therapeutiques pour streptococcus pyogenes
|
EP1838317A4
(fr)
|
2005-01-05 |
2012-02-29 |
Univ Minnesota |
Conjugues analgesiques
|
US7531541B2
(en)
|
2005-09-20 |
2009-05-12 |
Vanderbilt University |
Partial mGluR5 antagonists for treatment of anxiety and CNS disorders
|
EP2303317A2
(fr)
|
2008-06-20 |
2011-04-06 |
Wyeth LLC |
Compositions et procédés d'utilisation d'orf 554 provenant de souches de streptocoques bêta-hémolytiques
|
WO2009155484A2
(fr)
|
2008-06-20 |
2009-12-23 |
Wyeth |
Compositions et procédés d'utilisation d'orf1358 provenant de souches de streptocoques bêta-hémolytiques
|
EP2356135B1
(fr)
*
|
2008-11-05 |
2017-10-25 |
Wyeth LLC |
Composition immunogène à multiples composants pour la prévention d'une maladie streptococcique bêta-hémolytique (bhs)
|